Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kate Muller

Showing results (21-30 of 25) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 25 results.
The American Journal of Gastroenterology|August 14, 2024
COBALT: A Confirmatory Trial of Obeticholic Acid in Primary Biliary Cholangitis With Placebo and External ControlsKris V Kowdley, Gideon M Hirschfield, Charles Coombs, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|August 15, 2021
Management, outcomes and survival of an Australian IgG4-SC cohort: The MOSAIC studyWilliam Kemp, Ammar Majeed, Joanne Mitchell, et al.
Hepatology Communications|April 1, 2026
The diagnosis and management of portal hypertension in cirrhosis: The Gastroenterological Society of Australia consensusAvik Majumdar, Jacinta Holmes, Stuart K Roberts, et al.
Hepatology Communications|September 25, 2022
Monitoring quality of care in hepatocellular carcinoma: A modified Delphi consensusAshika D Maharaj, John Lubel, Eileen Lam, et al.
Open Forum Infectious Diseases|April 23, 2024
Hepatitis C Virus Antiviral Drug Resistance and Salvage Therapy Outcomes Across AustraliaDao Sen Wang, Amy Phu, Kristen McKee, et al.
Pageof 3

Showing results (21-30 of 25) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 25 results.
The American Journal of Gastroenterology|August 14, 2024
COBALT: A Confirmatory Trial of Obeticholic Acid in Primary Biliary Cholangitis With Placebo and External ControlsKris V Kowdley, Gideon M Hirschfield, Charles Coombs, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|August 15, 2021
Management, outcomes and survival of an Australian IgG4-SC cohort: The MOSAIC studyWilliam Kemp, Ammar Majeed, Joanne Mitchell, et al.
Hepatology Communications|April 1, 2026
The diagnosis and management of portal hypertension in cirrhosis: The Gastroenterological Society of Australia consensusAvik Majumdar, Jacinta Holmes, Stuart K Roberts, et al.
Hepatology Communications|September 25, 2022
Monitoring quality of care in hepatocellular carcinoma: A modified Delphi consensusAshika D Maharaj, John Lubel, Eileen Lam, et al.
Open Forum Infectious Diseases|April 23, 2024
Hepatitis C Virus Antiviral Drug Resistance and Salvage Therapy Outcomes Across AustraliaDao Sen Wang, Amy Phu, Kristen McKee, et al.
Pageof 3